Evidence map›Paper›PMID 27104873›Full record

ReviewAnnals of the American Thoracic Society2016

Frailty in Pulmonary and Critical Care Medicine.

Jonathan P Singer, David J Lederer, Matthew R Baldwin

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Annals of the American Thoracic Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03636412 (Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients), which is not on this map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03636412 nacompletednot on this mapstarted 2018, after this paper: background citation

Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients

TypeinterventionalSponsorThe Cleveland ClinicRan2018 to 2024Enrolled200ConditionsTransplant-Related Disorder, Frail Elderly Syndrome, Sarcopenia, Lung Graft DysfunctionArmsAmbulation
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Frailty in Pulmonary Arterial Hypertension: A Cohort Study.Annals of the American Thoracic Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Subphenotypes of frailty in lung transplant candidates.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  15. Article
  16. Article
  17. Is Frailty Diagnosis Important in Patients with COPD? A Narrative Review of the Literature.International journal of environmental research and public health · 2023
    Review
  18. Body Composition and COPD: A New Perspective.International journal of chronic obstructive pulmonary disease · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jonathan P Singer1 Department of Medicine, University of California San Francisco, San Francisco, California.
David J Lederer2 Department of Medicine and.
Matthew R Baldwin4 Department of Medicine, Columbia University Medical Center, New York, New York.
Columbia University Irving Medical Center · USUniversity of California, San Francisco · US

Funding

The Effects of Lung Transplant on Disability and Health-Related Quality of LifeK23HL111115 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SINGER, JONATHAN PAUL · 2012 to 2016
$832k
Frailty, Palliative Care Needs, and Outcomes in Older Survivors of Critical IllneK23AG045560 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BALDWIN, MATTHEW R · 2014 to 2018
$750k
NHLBI NIH HHS K23 HL111115NIA NIH HHS K23 AG045560NIA NIH HHS L30 AG040838
6 · The paper itself

Abstract

Conceptualized first in the field of geriatrics, frailty is a syndrome characterized by a generalized vulnerability to stressors resulting from an accumulation of physiologic deficits across multiple interrelated systems. This accumulation of deficits results in poorer functional status and disability. Frailty is a "state of risk" for subsequent disproportionate declines in health status following new exposure to a physiologic stressor. Two predominant models have emerged to operationalize the measurement of frailty. The phenotype model defines frailty as a distinct clinical syndrome that includes conceptual domains such as strength, activity, wasting, and mobility. The cumulative deficit model defines frailty by enumerating the number of age-related things wrong with a person. The biological pathways driving frailty include chronic systemic inflammation, sarcopenia, and neuroendocrine dysregulation, among others. In adults with chronic lung disease, frailty is independently associated with more frequent exacerbations of lung disease, all-cause hospitalization, declines in functional status, and all-cause mortality. In addition, frail adults who become critically ill are more likely develop chronic critical illness or severe disability and have higher in-hospital and long-term mortality rates. The evaluation of frailty appears to provide important prognostic information above and beyond routinely collected measures in adults with chronic lung disease and the critically ill. The study of frailty in these populations, however, requires multipronged efforts aimed at refining clinical assessments, understanding the mechanisms, and developing therapeutic interventions.

Indexed as

Critical IllnessHealth StatusAgedBody CompositionCritical CareDisability EvaluationFrailtyHumansLung DiseasesQuality of Lifebody compositiondisabilityfrailtyhealth-related quality of lifemortality

Identifiers

PMID27104873
PMCPMC5021078
OpenAlexW2339281117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.